Let Me Tell You More About My Depressed, Miserable Existence
By Depressed Jane on October 31, 2008
The suicide rate in older women of South Asian origin is increasing, according to new research published in the November issue of the British Journal of Psychiatry. Suicide rates among those over the age of 65 are now double that of other women living in England and Wales. The psychiatrists who carried out the study describe the finding as “a matter of concern” and call for further research into the reasons underlying the trend.
Popularity: unranked [?]
By Depressed Jane on October 31, 2008
An epidemiological study performed in Spain discloses a relationship between high blood pressure and depression in the elderly in the current issue of Psychotherapy and Psychosomatics. A positive association between hypertension and depression has been reported in some inquiries but not in others, and the relationship was limited to individuals with diastolic blood pressure (DBP) in some studies.
Popularity: unranked [?]
By Depressed Jane on October 30, 2008
With suicide the second-leading cause of death for Wyoming youths ages 15-19, the Wyoming Department of Health is beginning a new program with public and private partners to help address the role of schools in youth suicide prevention.
Popularity: unranked [?]
By Depressed Jane on October 30, 2008
The Maine Youth Suicide Prevention Program (MYSPP) recently learned that it has been selected to receive a $500,000 grant to enhance its efforts in high schools across the state. The U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) awarded 18 grants totaling almost $27 million over three years. Awards ranged form $317,000 to $500,000. This is the second Garret Lee Smith SAMHSA youth suicide prevention award received by MSYPP.
Popularity: unranked [?]
By Depressed Jane on October 30, 2008
An epidemiological study performed in Spain discloses a relationship between high blood pressure and depression in the elderly in the current issue of Psychotherapy and Psychosomatics. A positive association between hypertension and depression has been reported in some inquiries but not in others, and the relationship was limited to individuals with diastolic blood pressure (DBP) in some studies.
Popularity: unranked [?]
By Depressed Jane on October 29, 2008
One in 50 people in England were in contact with NHS specialist services for those with severe or enduring mental health problems in 2006-07, according to a new report by The NHS Information Centre. The number accessing specialist services, which cover care by specialist psychiatric teams in hospital or in the community, has risen over the four years covered by the report, reaching more than 1.1 million in 2006-07.
Popularity: unranked [?]
By Depressed Jane on October 29, 2008
According to national statistics, one out of four college students will experience some form of depression by the age of 24, and nearly half of all college students report feeling so depressed at some point in time that they have trouble functioning.
Popularity: unranked [?]
By Depressed Jane on October 28, 2008
“Ethnic Differences in the Treatment of Depression in Patients With Ischemic Heart Disease,” American Heart Journal: The study examines the differences in depressive symptoms and antidepressant treatment among blacks and whites undergoing a coronary angiography to diagnose heart disease.
Popularity: unranked [?]
By Depressed Jane on October 28, 2008
Youth in their late teens who live in poor neighbourhoods are four times more likely to attempt suicide than peers who live in more affluent neighbourhoods, according to a new study from Canada’s Université de Montréal and Sainte-Justine Hospital Research Center, as well as Tufts University in the U.S. The researchers also found youth from poor neighbourhoods are twice as likely to report suicidal thoughts.
Popularity: unranked [?]
By Depressed Jane on October 28, 2008
Auspex Pharmaceuticals, a developer of next-generation medicines with improved safety and performance through the targeted deuteration of clinically validated drugs, today announced positive results from its Phase 1 clinical trial evaluating SD-254, a Selective Serotinin-Norepinephrine Reuptake Inhibitor (SNRI). Auspex is developing SD-254, a deuterium-substituted version of venlafaxine, for the treatment of Major Depressive Disorder.
Popularity: unranked [?]
